Trailing-twelve-month (TTM) revenue is $603.64 Million with a year-over-year growth of (1.42%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $136,665,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $156,821,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-26 |
| Q1 FY2026Period ended 2026-03-31 | $155,075,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $155,075,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $603,636,000 |
Current P/S: $1,320,074,437 market capitalization ÷ $603,636,000 TTM revenue = 2.19x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $155.07M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T20:47:51.236Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| Fiduciary and Trust | $10M | $10M | $11M | $12M |
$603.64M
$603.64 Million
(1.42%)
vs. $612.33M a year ago (TTM)
+22.72%
5 Year compound annual growth rate
1 Year
(1.42%)
3 Year
+13.66%
5 Year
+22.72%
10 Year
+14.30%
15 Year
+12.17%
20 Year
+7.87%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $618.38M | +$2.48M | +0.40% |
| 2024 | $615.90M | +$93.40M | +17.88% |
| 2023 | $522.50M | +$182.73M | +53.78% |
| 2022 | $339.77M | +$95.48M | +39.08% |
| 2021 | $244.30M | +$31.01M | +14.54% |
| 2020 |
TTM Growth
(1.42%)
3-Year CAGR
+13.66%
5-Year CAGR
+22.72%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| $213.29M |
| ($14.68M) |
| (6.44%) |
| 2019 | $227.97M | +$25.67M | +12.69% |
| 2018 | $202.29M | +$26.01M | +14.75% |
| 2017 | $176.29M | +$14.84M | +9.19% |
| 2016 | $161.45M | +$10.25M | +6.78% |
